Target Group is expanding its global operations to build an international network of manufacturing, distribution, production, and sales operations. The Company owns and operates Canary RX Inc, a Health Canada licensed producer under The Cannabis Act (Bill C-45), and CannaKorp, makers of the pod-based Wisp™ Vapor technology. Target Group is curating an iconic brand portfolio, leveraging product diversification, innovation, and operational expertise to solidify long-term growth and stability. ("Target Group" or the "Company") is a progressive, diversified, and vertically integrated cannabis acquisition company. Canary's talented team will cultivate premium, craft cannabis, while aligning with distinguished, craft-focused consumer brands to bring the highest quality product to market. The production space includes eight separate craft flower rooms, projected to produce up to 4,500kg of cannabis annually. facility is engineered to meet strict quality standards and equipped with the latest environmental control technology. Situated in Ontario's Garden, Norfolk County, Canary lies nestled amongst the shores of Lake Erie in a vibrant, agricultural community. ("Canary") is a Licensed Producer under the Cannabis Act. Establishing predictable revenue streams with several significant partners are at the core of the company's strategy to expand its market reach and production capabilities in the craft at scale segment.Ĭanary Rx Inc. The Company continues to aggressively pursue long-term contracts with key purchasers. Continuing arrangements such as this with multiple major distributors will ensure Canary's position as a fixture in the Canadian supply landscape.
Canary flower has all the attributes required of premium craft flower to maintain anticipated price thresholds in a challenging marketplace.